%0 Journal Article
%T Prevalence of Non-<i>Albicans Candida</i> Infections in Women with Recurrent Vulvovaginal Symptomatology
%A Jason D. Mintz
%A Mark G. Martens
%J Advances in Infectious Diseases
%P 238-242
%@ 2164-2656
%D 2013
%I Scientific Research Publishing
%R 10.4236/aid.2013.34035
%X <p class=\"MsoNormal\" style=\"text-align:justify;\">
	<b><span lang=\"EN-US\" style=\"font-family:Verdana;\">Background:</span></b><span lang=\"EN-US\"> </span><i><span lang=\"EN-US\" style=\"font-family:Verdana;\">Candida</span></i><span lang=\"EN-US\"><span style=\"font-family:Verdana;\"> vulvovaginitis is one of the most frequently
diagnosed conditions in womenĄŻs care practices. Historically, 90% of cultured
yeast species were </span><i><span style=\"font-family:Verdana;\">C. albicans</span></i><span style=\"font-family:Verdana;\">. However,
due to a variety of interventions</span></span><span lang=\"EN-US\" style=\"font-family:Verdana;\">,</span><span lang=\"EN-US\"><span style=\"font-family:Verdana;\"> the proportion of non-</span><i><span style=\"font-family:Verdana;\">albicans
Candida</span></i><span style=\"font-family:Verdana;\"> (NAC) infections appears to be increasing. We sought to estimate
the current prevalence of </span><i><span style=\"font-family:Verdana;\">Candida</span></i><span style=\"font-family:Verdana;\"> vulvovaginitis and the species-specific distribution of such infections in
recurrent cases.</span></span><span lang=\"EN-US\"> </span><b><span lang=\"EN-US\" style=\"font-family:Verdana;\">Methods:</span></b><span lang=\"EN-US\"><span style=\"font-family:Verdana;\"> Women with recurrent vulvovaginal symptomatology
referred to an Obstetrics and Gynecology practice were tested by genital </span><span style=\"letter-spacing:.1pt;\"><span style=\"font-family:Verdana;\">fungus culture, </span><i><span style=\"font-family:Verdana;\">Candida</span></i><span style=\"font-family:Verdana;\">-specific
polymerase chain reaction (PCR), or both between July 2010 and February 2013. </span><b><span style=\"font-family:Verdana;\">Re</span></b></span><b><span style=\"font-family:Verdana;\">sults:</span></b><span style=\"font-family:Verdana;\"> A total of 103 women were tested. Mean age was 45.6 years. Including
only their most recent positive test result, 29.1% (30/103) of women tested
positive for </span><i><span style=\"font-family:Verdana;\">Candida</span></i><span style=\"font-family:Verdana;\"> by any of the
above testing measures</span><i><span style=\"font-family:Verdana;\">. </span></i><span style=\"font-family:Verdana;\">Of those, 50%
(15/30) tested positive for </span><i><span style=\"font-family:Verdana;\">C. albicans</span></i><span style=\"font-family:Verdana;\"> and 50% (15/30) tested positive for a NAC species. Across all visits, 60%
(18/30) tested positive for </span><i><span style=\"font-family:Verdana;\">C.
%K Recurrent Vulvovaginal Candidiasis
%K Non--&lt
%K i&gt
%K Albicans Candida&lt
%K /i&gt
%K Fluconazole
%K Yeast Infections
%K Candida Vaginitis
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=40366